Doaa Boshra Farag

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

Gayathri Nair Sekhar, Alice L. Fleckney, Sevda Boyanova et al. · Fluids and Barriers of the CNS · 2019 · 54 citations · Full text

Crocin attenuates cisplatin-induced hepatotoxicity via TLR4/NF-κBp50 signaling and BAMBI modulation of TGF-β activity: Involvement of miRNA-9 and miRNA-29

Lobna H. Khedr, Rania M. Rahmo, Doaa Boshra Farag et al. · Food and Chemical Toxicology · 2020 · 30 citations

Tgf-β Activity, Cell Regulation, Medicine +10

Synthesis, 3D pharmacophore, QSAR and docking studies of novel quinazoline derivatives with nitric oxide release moiety as preferential COX-2 inhibitors

Doaa Boshra Farag, Nahla A. Farag, Ahmed Esmat et al. · MedChemComm · 2014 · 28 citations

Combinatorial Chemistry, Novel Quinazoline Derivatives, Bioorganic Chemistry +17

Targeting Subcellular Localization through the Polo-Box Domain: Non-ATP Competitive Inhibitors Recapitulate a PLK1 Phenotype

Campbell McInnes, Kara Estes, Merissa Baxter et al. · Molecular Cancer Therapeutics · 2012 · 26 citations · Full text

Drug Target, Subcellular Localization, Molecular Biology +18

Ameliorative effect of betanin on experimental cisplatin‐induced liver injury; the novel impact of miRNA‐34a on the SIRT1/PGC‐1α signaling pathway

Ismail El Shaffei, Ghada A. Abdel‐Latif, Doaa Boshra Farag et al. · Journal of Biochemical and Molecular Toxicology · 2021 · 17 citations